November 28, 2016 Intelligence: Late Breaking Lab News

Share on facebook
Share on twitter
Share on linkedin
Share on print
Share on email

In recent weeks, two different lab transactions were announced. One involved a hospital laboratory management contract and the other was a potential merger of two anatomic pathology lab companies. The first announcement came on October 31, when Lovelace Health System of Albuquerque, New Mexico, released news that it entered into an “inpatient and outpatient laboratory management service” contract with TriCore Reference Laboratories, also based in Albuquerque. The new management services pact takes effect on February 21, 2017. This transaction is a setback for Quest Diagnostics Incorporated, which had held the hospital laboratory management services contract with Lovelace since 2012, when it acquired SED Laboratories, then owned by Lovelace.

MORE ON: Lab Deals

The second transaction involves two pathology lab companies in Seattle. On November 4, Pacific Institute of Pathology (PSIP) and CellNetix, Inc., disclosed a memorandum of understanding to explore a merger of their respective pathology businesses. Currently 17 pathologists work at PSIP while 50 pathologists are at CellNetix. If this merger takes place, it will represent further consolidation of private practice pathology groups in Washington state.


The recent election is apparently one reason that the Food and Drug Administration (FDA) will not release final guidance to regulate laboratory-developed tests (LDTs) until it has worked with the new Congress and other stakeholders on this issue. The agency issued this statement on November 18.


  • Rosetta Genomics of Philadelphia, Penna., named Mark R. Willig as Chief Commercial Officer. Willig has served at CardioDx, Agendia, Exiqon, Thermo Fisher Scientific, Cleveland Heart Lab (Prognostix), Specialty Laboratories, Myriad Genetics, and Abbott Diagnostics.
  • David C. Weavil joined the board of directors of Acuamark Diagnostics, of New York, NY. Weavil is currently CEO of Solstas Lab Partners, LLC, a division of Quest Diagnostics Incorporated. He has held executive positions with Specialty Laboratories, Unilab Inc., Laboratory Corporation of America, and Roche Biomedical Laboratories.

dark_daily_logoHave you caught the latest e-briefings from DARK Daily? If so, then you’d know about …
…a new collaboration involving IBM Watson Health and other entities that want a solution to unstructured data. The focus will be on radiology images, but pathology data will also be studied as part of this effort.

You can get the free DARK Daily e-briefings by signing up at

That’s all the insider intelligence for this report.
Look for the next briefing on Monday, December 19, 2016.

Screenshot 2016-11-30 14.41.47


Leave a Reply


You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

Privacy Policy: We will never share your personal information.